Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists

Depression, Stress, and Anhedonia: Toward a Synthesis and Integrated Model

(2014) Diego A. Pizzagalli   Annual Review of Clinical Psychology

Antidepressant effects of resveratrol in an animal model of depression

(2014) Laura L. Hurley et al.   BEHAVIOURAL BRAIN RESEARCH

The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats

(2014) S. Sommer et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The VMAT-2 Inhibitor Tetrabenazine Affects Effort-Related Decision Making in a Progressive Ratio/Chow Feeding Choice Task: Reversal with Antidepressant Drugs

(2014) Patrick A. Randall et al.   PLoS One

Negative Symptoms of Schizophrenia Are Associated with Abnormal Effort-Cost Computations

(2013) James M. Gold et al.   BIOLOGICAL PSYCHIATRY

Effort-Related Motivational Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Animal Models of the Motivational Symptoms of Depression

(2013) E. J. Nunes et al.   JOURNAL OF NEUROSCIENCE

Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation

(2013) P Trifilieff et al.   MOLECULAR PSYCHIATRY

Blockade of D3 receptors by YQA14 inhibits cocaine's rewarding effects and relapse to drug-seeking behavior in rats

(2013) Rui Song et al.   NEUROPHARMACOLOGY

The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: Implications for pharmacological models of parkinsonian tremor

(2013) S.J. Podurgiel et al.   NEUROSCIENCE

Measuring reinforcement learning and motivation constructs in experimental animals: Relevance to the negative symptoms of schizophrenia

(2013) Athina Markou et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

The Mysterious Motivational Functions of Mesolimbic Dopamine

(2012) John D. Salamone et al.   NEURON

Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice

(2012) M. Pardo et al.   NEUROPHARMACOLOGY

Dissociation of Hedonic Reaction to Reward and Incentive Motivation in an Animal Model of the Negative Symptoms of Schizophrenia

(2012) Ryan D Ward et al.   NEUROPSYCHOPHARMACOLOGY

Sensitivity to Cognitive Effort Mediates Psychostimulant Effects on a Novel Rodent Cost/Benefit Decision-Making Task

(2012) Paul J Cocker et al.   NEUROPSYCHOPHARMACOLOGY

Dopaminergic Modulation of Effort-Related Choice Behavior as Assessed by a Progressive Ratio Chow Feeding Choice Task: Pharmacological Studies and the Role of Individual Differences

(2012) Patrick A. Randall et al.   PLoS One

Lesions of the dopaminergic innervation of the nucleus accumbens medial shell delay the generation of preference for sucrose, but not of sexual pheromones

(2011) José Martínez-Hernández et al.   BEHAVIOURAL BRAIN RESEARCH

Motivational states influence effort-based decision making in rats: The role of dopamine in the nucleus accumbens

(2011) Bettina Mai et al.   COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE

Dopamine D3 receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats

(2011) Amanda E. Higley et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Role of dopamine D3 and serotonin 5-HT1A receptors in l-DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson’s disease

(2011) Manfred Gerlach et al.   JOURNAL OF NEURAL TRANSMISSION

Dopamine D3-Like Receptors Modulate Anxiety-Like Behavior and Regulate GABAergic Transmission in the Rat Lateral/Basolateral Amygdala

(2011) Marvin R Diaz et al.   NEUROPSYCHOPHARMACOLOGY

Disentangling pleasure from incentive salience and learning signals in brain reward circuitry

(2011) K. S. Smith et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders

(2010) David R.P. Guay   American Journal Geriatric Pharmacotherapy

Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism

(2010) E.J. Nunes et al.   NEUROSCIENCE

Reconsidering anhedonia in depression: Lessons from translational neuroscience

(2010) Michael T. Treadway et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Dopamine modulates effort-based decision making in rats.

(2009) Mark E. Bardgett et al.   BEHAVIORAL NEUROSCIENCE

Tetrabenazine

(2009) Alfonso Fasano et al.   EXPERT OPINION ON PHARMACOTHERAPY

The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure

(2009) Allison M. Mott et al.   PSYCHOPHARMACOLOGY

Dopamine, Behavioral Economics, and Effort

(2009) John D. Salamone   Frontiers in Behavioral Neuroscience

Cortico-limbic-striatal circuits subserving different forms of cost-benefit decision making

(2008) S. B. Floresco et al.   COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE

The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists

(2008) Lila T. Worden et al.   PSYCHOPHARMACOLOGY

Affective neuroscience of pleasure: reward in humans and animals

(2008) Kent C. Berridge et al.   PSYCHOPHARMACOLOGY